STAAR Surgical Return on Tangible Equity 2010-2023 | STAA
Current and historical return on tangible equity values for STAAR Surgical (STAA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| STAAR Surgical Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2023-12-31 |
$0.02B |
$0.38B |
6.07% |
| 2023-09-30 |
$0.02B |
$0.38B |
6.00% |
| 2023-06-30 |
$0.03B |
$0.35B |
7.76% |
| 2023-03-31 |
$0.03B |
$0.34B |
10.26% |
| 2022-12-31 |
$0.04B |
$0.33B |
13.08% |
| 2022-09-30 |
$0.04B |
$0.32B |
14.31% |
| 2022-06-30 |
$0.04B |
$0.30B |
13.77% |
| 2022-03-31 |
$0.03B |
$0.27B |
13.06% |
| 2021-12-31 |
$0.03B |
$0.26B |
11.80% |
| 2021-09-30 |
$0.02B |
$0.25B |
10.37% |
| 2021-06-30 |
$0.02B |
$0.23B |
10.19% |
| 2021-03-31 |
$0.01B |
$0.21B |
5.76% |
| 2020-12-31 |
$0.01B |
$0.20B |
3.36% |
| 2020-09-30 |
$0.01B |
$0.18B |
5.31% |
| 2020-06-30 |
$0.01B |
$0.17B |
4.37% |
| 2020-03-31 |
$0.01B |
$0.16B |
7.87% |
| 2019-12-31 |
$0.01B |
$0.16B |
8.93% |
| 2019-09-30 |
$0.01B |
$0.15B |
5.78% |
| 2019-06-30 |
$0.01B |
$0.14B |
5.24% |
| 2019-03-31 |
$0.01B |
$0.14B |
4.54% |
| 2018-12-31 |
$0.01B |
$0.13B |
5.71% |
| 2018-09-30 |
$0.00B |
$0.13B |
6.13% |
| 2018-06-30 |
$0.00B |
$0.05B |
9.25% |
| 2018-03-31 |
$0.00B |
$0.04B |
2.50% |
| 2017-12-31 |
$-0.00B |
$0.04B |
-5.30% |
| 2017-09-30 |
$-0.00B |
$0.04B |
-5.48% |
| 2017-06-30 |
$-0.01B |
$0.04B |
-14.08% |
| 2017-03-31 |
$-0.01B |
$0.04B |
-16.90% |
| 2016-12-31 |
$-0.01B |
$0.04B |
-33.57% |
| 2016-09-30 |
$-0.01B |
$0.04B |
-36.36% |
| 2016-06-30 |
$-0.01B |
$0.04B |
-35.86% |
| 2016-03-31 |
$-0.01B |
$0.04B |
-35.62% |
| 2015-12-31 |
$-0.01B |
$0.04B |
-19.44% |
| 2015-09-30 |
$-0.01B |
$0.04B |
-25.35% |
| 2015-06-30 |
$-0.01B |
$0.04B |
-27.97% |
| 2015-03-31 |
$-0.01B |
$0.03B |
-27.59% |
| 2014-12-31 |
$-0.01B |
$0.03B |
-24.16% |
| 2014-09-30 |
$-0.01B |
$0.04B |
-18.54% |
| 2014-06-30 |
$-0.00B |
$0.04B |
-8.16% |
| 2014-03-31 |
$-0.00B |
$0.04B |
-2.88% |
| 2013-12-31 |
$0.00B |
$0.04B |
0.00% |
| 2013-09-30 |
$0.00B |
$0.03B |
0.00% |
| 2013-06-30 |
$-0.00B |
$0.03B |
-3.45% |
| 2013-03-31 |
$-0.00B |
$0.03B |
-3.57% |
| 2012-12-31 |
$-0.00B |
$0.03B |
-3.67% |
| 2012-09-30 |
$0.00B |
$0.03B |
0.00% |
| 2012-06-30 |
$0.00B |
$0.03B |
0.00% |
| 2012-03-31 |
$0.00B |
$0.03B |
4.26% |
| 2011-12-31 |
$0.00B |
$0.03B |
4.65% |
| 2011-09-30 |
$0.00B |
$0.02B |
0.00% |
| 2011-06-30 |
$-0.00B |
$0.02B |
-5.63% |
| 2011-03-31 |
$-0.00B |
$0.02B |
-23.88% |
| 2010-12-31 |
$0.00B |
$0.02B |
0.00% |
| 2010-09-30 |
$0.00B |
$0.02B |
0.00% |
| 2010-06-30 |
$-0.00B |
$0.02B |
-7.69% |
| 2010-03-31 |
$0.00B |
$0.02B |
0.00% |
| 2009-12-31 |
$-0.01B |
$0.01B |
-75.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.275B |
$0.322B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
